Kaori Kitae
Suita, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
An ALKBH3 Inhibitor HUHS199 Suppresses Proliferation of Glioblastoma Cells by Targeting 1-Methyladenosine on GADD45A mRNA.
Journal: Chemical biology & drug design
Published: April 02, 2026
CGRPβ suppresses the pathogenesis of ulcerative colitis via the immunoproteasome.
Journal: Scientific reports
Published: September 12, 2024
RNA-modifying enzyme Alkbh8 is involved in mouse embryonic development.
Journal: iScience
Published: January 22, 2024
ALKBH8 contributes to neurological function through oxidative stress regulation.
Journal: PNAS nexus
Published: November 10, 2023
ALKBH4 is a novel enzyme that promotes translation through modified uridine regulation.
Journal: The Journal of biological chemistry
Published: January 11, 2023
Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
Journal: Chemical biology & drug design
Published: November 25, 2021
Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Journal: International journal of molecular sciences
Published: January 28, 2021
Development of a highly sensitive method for the quantitative analysis of modified nucleosides using UHPLC-UniSpray-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 13, 2020
ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer.
Journal: Scientific reports
Published: September 08, 2020
Cancer type‑SLCO1B3 promotes epithelial‑mesenchymal transition resulting in the tumour progression of non‑small cell lung cancer.
Journal: Oncology reports
Published: July 17, 2020
Last Updated: 09/26/2026